Background: Even with high standards of acute care and neurological early rehabilitation (NER) a substantial number of patients with neurological conditions still need mechanical ventilation and/or airway protection by tracheal cannulas when discharged and hence home-based specialised intensive care nursing (HSICN). It may be possible to improve the home care situation with structured specialized long-term neurorehabilitation support and following up patients with neurorehabilitation teams. Consequently, more people might recover over an extended period to a degree that they were no longer dependent on HSICN.
Methods: This healthcare project and clinical trial implements a new specialised neurorehabilitation outreach service for people being discharged from NER with the need for HSICN. The multicentre, open, parallel-group RCT compares the effects of one year post-discharge specialized outpatient follow-up to usual care in people receiving HSICN. Participants will randomly be assigned to receive the new form of healthcare (intervention) or the standard healthcare (control) on a 2:1 basis. Primary outcome is the rate of weaning from mechanical ventilation and/or decannulation (primary outcome) after one year, secondary outcomes include both clinical and economic measures. 173 participants are required to corroborate a difference of 30 vs. 10% weaning success rate statistically with 80% power at a 5% significance level allowing for 15% attrition.
Discussion: The OptiNIV-Study will implement a new specialised neurorehabilitation outreach service and will determine its weaning success rates, other clinical outcomes, and cost-effectiveness compared to usual care for people in need for mechanical ventilation and/or tracheal cannula and hence HSICN after discharge from NER.
Trial Registration: The trial OptiNIV has been registered in the German Clinical Trials Register (DRKS) since 18.01.2022 with the ID DRKS00027326 .
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351064 | PMC |
| http://dx.doi.org/10.1186/s12883-022-02814-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Building a growing genomic repository for maternal and fetal health through the PING Consortium.
Pediatr Res
January 2025
Center for Genetic Medicine, Children's National Research Institute, Washington, DC, USA.
Background: Prenatally transmitted viruses can cause severe damage to the developing brain. There is unexplained variability in prenatal brain injury and postnatal neurodevelopmental outcomes, suggesting disease modifiers. Of note, prenatal Zika infection can cause a spectrum of neurodevelopmental disorders, including congenital Zika syndrome.
View Article and Find Full Text PDFEvolution of dizziness-related disability in children following concussion: a group-based trajectory analysis.
Brain Inj
January 2025
School of Physical and Occupational Therapy, McGill University, Montréal, Canada.
Article Synopsis
- This study explored the recovery trajectories of Dizziness-Related Disability (DRD) in kids aged 8-17 who experienced concussions, using evaluations over 6 months.
- Two main recovery groups were identified: a Low DRD group (79% of participants) and a High DRD group (21%).
- Key factors predicting membership in the High DRD group included chronic neck pain, existing anxiety issues, and scores from a specific assessment tool (the 5P total score), highlighting the need for personalized treatment approaches.
Analysis of Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society.
Neurology
September 2024
From the Department of Neurology (J.M.M.), Wake Forest University School of Medicine, Winston-Salem, NC; Providence Health and Services (A.L.C.), OR; Department of Pediatrics (G.Y.G.), Emory University School of Medicine, Children's Healthcare of Atlanta, GA; Department of Neurology (B.R.A.), School of Medicine, Washington University in St Louis and St Louis Children's Hospital, MO; Department of Neurology (L.J.), University of Virginia, Charlottesville; Division of Pediatric Neurology (S.J.), Department of Pediatrics, University of Michigan, Ann Arbor; Department of Neurology (J.B.S.), University of California, San Francisco; Child Neurology Society (M.T.), Minneapolis, MN; LSU Health Sciences Center and Children's Hospital New Orleans (A.H.T.), LA; Department of Neurology (P.L.P.), Harvard Medical School, Boston, MA; Department of Physical Medicine and Rehabilitation (J.K.S.), Harvard Medical School; Spaulding Rehabilitation Hospital (J.K.S.); Massachusetts General Hospital (J.K.S.); Brigham and Women's Hospital (J.K.S.), Boston, MA; Pittsford, NY (J.W.M.); and Division of Child Neurology (Y.K.), Departments of Pediatrics and Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.
Article Synopsis
- The study investigates gender representation in leadership positions and award recipients within the Child Neurology Society (CNS) over a 50-year period, from 1972 to 2023.
- Despite women making up the majority of child neurology trainees since 2007, they hold only 29% of board positions and 26% of post-training awards, indicating a persistent gender gap.
- While the number of women in nonpresidential roles has increased, only 13% of CNS presidents have been women, highlighting significant underrepresentation in top leadership positions.
The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019.
BMC Public Health
May 2024
Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Background: The European Union (EU) faces many health-related challenges. Burden of diseases information and the resulting trends over time are essential for health planning. This paper reports estimates of disease burden in the EU and individual 27 EU countries in 2019, and compares them with those in 2010.
View Article and Find Full Text PDFAsian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians.
Alzheimers Dement
March 2024
Penn Neurodegeneration Genomics Center, Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Introduction: Clinical research in Alzheimer's disease (AD) lacks cohort diversity despite being a global health crisis. The Asian Cohort for Alzheimer's Disease (ACAD) was formed to address underrepresentation of Asians in research, and limited understanding of how genetics and non-genetic/lifestyle factors impact this multi-ethnic population.
Methods: The ACAD started fully recruiting in October 2021 with one central coordination site, eight recruitment sites, and two analysis sites.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!